AA
INSM icon

Ancora Advisors’s Insmed INSM Stock Holding History

Ancora Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
200
-14
-7% -$1.7K ﹤0.01% 1301
2026
Q1 		$35K Hold
214
– – ﹤0.01% 1300
2025
Q4 		$37.2K Buy
+214
New +$39.1K ﹤0.01% 1256

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Ancora Advisors's INSM Position: Q2 2026 in Review

Ancora Advisors reduced its Insmed (INSM) stake by 6.5% in Q2 2026, selling an estimated $1.7K and leaving 200 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Ancora Advisors first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $37.2K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Ancora Advisors held 200 shares of Insmed worth $21.3K as of Q2 2026.
  • Ancora Advisors sold 14 Insmed shares in Q2 2026, an estimated $1.7K.
  • Insmed made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1301 holding.
  • Ancora Advisors first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
  • Ancora Advisors's Insmed position peaked at $37.2K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.